Greenwood Village, Colorado — February 4, 2019 — /D.M.O. Newswire/ — Helix TCS Inc.‘s (OTC:HLIX) (the “Company”) subsidiary, BioTrackTHC, today announced that it has been tapped by the State of Illinois to provide the software solution that will track medical cannabis sales for patients participating in the state’s Opioid Alternative Pilot Program. BioTrackTHC is already responsible for tracking and tracing the state’s medical cannabis supply chain, and its software now provides a unified solution for these programs.
“As research continues to drive medical cannabis as an alternative to prescription painkillers, Helix TCS is uniquely positioned to deliver the critical tracking and compliance technology infrastructure surrounding both forms of medicine in existing and emerging medical and recreational cannabis markets, through our subsidiary BioTrackTHC, and will be able to leverage tracking data to directly correlate changes in opioid use to medical cannabis expansion,” said Zachary L. Venegas, Executive Chairman and CEO of Helix TCS, Inc...
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.